Lexeo Therapeutics Inc (LXEO)

SG&A Expenses

$28.48M

TTM · Period ending: · USD

LXEO logo

LXEO SG&A Expenses

Latest reported$28.48M
LXEO TTM SG&A Expenses ($11.99M → $28.48M)
High-resolution chart · PNG

LXEO sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lexeo Therapeutics Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
28,482,000
35,456,000
45,460,000
47,570,000
49,737,000
40,760,000
31,675,000
29,423,000
24,330,000
20,079,000
15,382,000
12,428,000
12,052,000
12,394,000
11,993,736
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.